Silence Therapeutics, Plc. earnings per share and revenue

SLNCF earnings per share for the last quarter are -0.01 USD whereas the estimation was -0.04 USD which accounts for 85.39% surprise. Företagets omsättning för samma period uppgår till 15.66 M USD trots den uppskattade siffran 6.35 M USD. Estimated earnings per share for the next quarter are -0.04 USD, and revenue is expected to reach 11.67 M USD. Also watch annual changes over time to get a bigger picture of SLNCF earnings per share and revenue dynamics.